ANI Pharmaceuticals, Inc. filed a current report on August 7, 2026, announcing its financial results for the second quarter ended June 30, 2026, and publishing an updated investor presentation to its website.

Key Highlights

  • Reporting period: Second quarter ended June 30, 2026.
  • Press release: A press release announcing financial results was issued on August 7, 2026, furnished as Exhibit 99.1.
  • Investor presentation: An updated investor presentation, dated August 2026, was published to the company's investor relations website and attached as Exhibit 99.2.
  • Exchange listing: Common Stock trades under the symbol ANIP on the Nasdaq Stock Market.
  • Signed by: Stephen P. Carey, Senior Vice President Finance and Chief Financial Officer.

ANI Pharmaceuticals Discloses Q2 2026 Results and Updated Investor Materials

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP), headquartered at 104 Carnegie Center Drive, Suite 300, Princeton, New Jersey, filed a current report on August 7, 2026, under Items 2.02 and 7.01 of the applicable reporting rules. According to the filing, the company issued a press release on that date announcing its financial results for the second quarter ended June 30, 2026. The press release is furnished as Exhibit 99.1 to the filing.

The filing also discloses, under Item 7.01 (Regulation FD Disclosure), that the company published an updated investor presentation to the investor relations section of its website on August 7, 2026. According to the filing, "the Company may use the updated investor presentation in various meetings with investors and analysts from time to time." The investor presentation, dated August 2026, is attached as Exhibit 99.2 and incorporated by reference.

The filing notes that the information reported under Items 2.02 and 7.01 "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section." The report was signed by Stephen P. Carey in his capacity as Senior Vice President Finance and Chief Financial Officer.

What Was Disclosed

ANI Pharmaceuticals reported its Q2 2026 financial results via press release and published an updated investor presentation on August 7, 2026, both furnished as exhibits to this current report filed with the SEC.